The Serine Hydrolase ABHD6 Is a Critical Regulator of the Metabolic Syndrome
Open Access
- 31 October 2013
- journal article
- Published by Elsevier BV in Cell Reports
- Vol. 5 (2), 508-520
- https://doi.org/10.1016/j.celrep.2013.08.047
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Evidence for a role of LPGAT1 in influencing BMI and percent body fat in Native AmericansObesity, 2013
- Quantitative analysis of glycerophospholipids by LC–MS: Acquisition, data handling, and interpretationBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2011
- Metabolomics annotates ABHD3 as a physiologic regulator of medium-chain phospholipidsNature Chemical Biology, 2011
- Dual Inhibition of α/β-Hydrolase Domain 6 and Fatty Acid Amide Hydrolase Increases Endocannabinoid Levels in NeuronsOnline Journal of Public Health Informatics, 2011
- Superfamily-wide portrait of serine hydrolase inhibition achieved by library-versus-library screeningProceedings of the National Academy of Sciences of the United States of America, 2010
- Mutations in ABHD12 Cause the Neurodegenerative Disease PHARC: An Inborn Error of Endocannabinoid MetabolismAmerican Journal of Human Genetics, 2010
- Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid systemNature Neuroscience, 2010
- The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptorsNature Neuroscience, 2010
- Characterization of Monoacylglycerol Lipase Inhibition Reveals Differences in Central and Peripheral Endocannabinoid MetabolismCell Chemical Biology, 2009
- A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-ArachidonoylglycerolCell Chemical Biology, 2007